CN Stock MarketDetailed Quotes

301230 Pharmaresources

Watchlist
  • 34.92
  • -1.18-3.27%
Market Closed Apr 30 15:00 CST
3.76BMarket Cap144.30P/E (TTM)

About Pharmaresources Company

Established in 2007, the company is a one-stop integrated service provider for small molecule innovative drug development and commercial production. It is committed to drug discovery, pharmaceutical process research and development, and commercial production of APIs and intermediates. The main business mainly covers drug discovery (CRO), process research and development (CRO/CDMO), and commercial production (including CMO). Main products and businesses: Drug discovery includes medicinal chemistry research, synthetic chemistry research, and pharmacokinetics research; process research and development includes process chemistry and process development and CMC research for APIs; commercial production includes customized production of new drugs (CMO) and R&D, production and sales of independent generic pharmaceutical products.

Company Profile

Short Name-A泓博医药
Symbol-A301230
Listing DateNov 1, 2022
Issue Price40.00
Shares Offered19.25M share(s)
FoundedDec 14, 2007
Legal RepresentativePING CHEN
CEOPING CHEN
Secretaryshengli jiang
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativeqiuli li
Legal CounselBeijing Jiayuan Law Firm
Employees580
Phone021-50720100
Office AddressBuilding 12, No. 59, Kaiqing Road, Pudong District, Shanghai
Zip Code201201
Registered AddressBuilding 23, No. 315, Qingda Road, Pudong District, Shanghai
Fax021-50720097-266
Emailinfo@pharmaresources.cn
Business License310115400237574
BusinessResearch and development of new drugs and related biotechnology, transfer of own technology, and provision of relevant technical services and advice (for projects requiring approval according to law, business activities can only be carried out after approval by relevant departments).

Company Executives

  • Name
  • Position
  • Salary
  • PING CHEN
  • Chairman,directors,general manager
  • 1.10M
  • rongchang an
  • directors,Audit Committee Member
  • --
  • shengli jiang
  • directors,Board Secretary,Deputy General Manager
  • 646.30K
  • zheng fei
  • directors
  • --
  • qidong you
  • Independent directors
  • 200.00K
  • li cheng
  • Independent directors
  • 200.00K
  • chunyang shao
  • Independent directors
  • 200.00K
  • qiuli li
  • Securities affairs representative
  • --
  • guodong liu
  • Chairman of the Supervisory Board,auditors
  • --
  • huizu wang
  • auditors
  • --
  • xuejun dong
  • auditors
  • 403.60K
  • ZHEN-WEI CAI
  • Deputy General Manager
  • 1.14M
  • haifeng li
  • Deputy General Manager
  • 1.20M
  • shicheng li
  • Chief Financial Officer
  • 538.70K
  • xiaojing he
  • Employee supervisors
  • 474.10K
  • peihua sun
  • Employee supervisors
  • 861.60K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg